« Glycated Haemogloin, Fasting Plasma Glucose, Plasminogen Activator Inhibitor Type-1, and Soluble Thrombomodulin Levels in Patients with Type 2 Diabetes Mellitus », NJPS, vol. 36, nᵒ 2, p. 159–164, déc. 2021, doi: 10.54548/njps.v36i2.3.